Machine learning in metastatic cancer research: Potentials, possibilities, and prospects

Comput Struct Biotechnol J. 2023 Mar 29:21:2454-2470. doi: 10.1016/j.csbj.2023.03.046. eCollection 2023.

Abstract

Cancer has received extensive recognition for its high mortality rate, with metastatic cancer being the top cause of cancer-related deaths. Metastatic cancer involves the spread of the primary tumor to other body organs. As much as the early detection of cancer is essential, the timely detection of metastasis, the identification of biomarkers, and treatment choice are valuable for improving the quality of life for metastatic cancer patients. This study reviews the existing studies on classical machine learning (ML) and deep learning (DL) in metastatic cancer research. Since the majority of metastatic cancer research data are collected in the formats of PET/CT and MRI image data, deep learning techniques are heavily involved. However, its black-box nature and expensive computational cost are notable concerns. Furthermore, existing models could be overestimated for their generality due to the non-diverse population in clinical trial datasets. Therefore, research gaps are itemized; follow-up studies should be carried out on metastatic cancer using machine learning and deep learning tools with data in a symmetric manner.

Keywords: Cancer metastasis; Data inequality; Deep learning; Early detection; Machine learning; Metastatic cancer.

Publication types

  • Review